Nature Communications (Oct 2020)

Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma

  • Laura Escudero,
  • Anna Llort,
  • Alexandra Arias,
  • Ander Diaz-Navarro,
  • Francisco Martínez-Ricarte,
  • Carlota Rubio-Perez,
  • Regina Mayor,
  • Ginevra Caratù,
  • Elena Martínez-Sáez,
  • Élida Vázquez-Méndez,
  • Iván Lesende-Rodríguez,
  • Raquel Hladun,
  • Luis Gros,
  • Santiago Ramón y Cajal,
  • Maria A. Poca,
  • Xose S. Puente,
  • Juan Sahuquillo,
  • Soledad Gallego,
  • Joan Seoane

DOI
https://doi.org/10.1038/s41467-020-19175-0
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 11

Abstract

Read online

Non-invasive and precise methods are critical for monitoring paediatric brain cancers. Here the authors show that the molecular alterations and heterogeneity of paediatric medulloblastomas can be reliably detected in circulating tumour DNA from the cerebrospinal fluid – a routinely collected sample.